SUBSCRIBE
SUBSCRIBE

Phase 1

Drug Development
New AIDS Approach Disrupts Patient’s DNA, Sangamo BioSciences, Inc. Announces
February 3, 2009
 · 
1 min read
Drug Development
ReNeuron To Launch Pioneering Stem Cell Trial
January 20, 2009
 · 
1 min read
Drug Development
Research Identifies Type Of Vaccine That Holds Promise In Protecting Against TB, St. Louis University School of Medicine Study
October 20, 2008
 · 
1 min read
Drug Development
Radioactive Scorpion Venom Could Be Used To Fight Brain Cancer, University of Chicago Study; Dosing Began In TransMolecular, Inc.'s Phase 1/2 Clinical Trial Of 131I-TM601
October 2, 2008
 · 
1 min read
Drug Development
University of Newcastle Scientists Test First Arthritis Vaccine; Patients’ Own Blood Cells Key To Rheumatoid Arthritis Vaccine
August 14, 2008
 · 
1 min read
Drug Development
Gilead Sciences, Inc. AIDS Drugs Will Be Tested To See If They Can Prevent HIV
August 4, 2008
 · 
1 min read
Drug Development
FDA (JOBS) to Exempt Early-Stage Drugs from GMP Regulations
July 17, 2008
 · 
1 min read
Drug Development
Solid Tumor Cells Not Killed By Radiation And Chemotherapy Become Stronger; Duke University Researchers Say Blocking HIF1 Could be the Answer
June 10, 2008
 · 
1 min read
Drug Development
New Vaccine Approach Prevents/Reverses Diabetes In Lab Study At Children’s Hospital of Pittsburgh
May 29, 2008
 · 
1 min read
Drug Development
New Hope For HIV Vaccine: Unique HIV Vaccine Formula, Developed By Advanced BioScience Laboratories, Inc. and The University of Massachusetts - Amherst, Elicits Strong Immune Responses, Findings Confirmed By University of Alabama at Birmingham Study
May 23, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds
February 26, 2026
 · 
2 min read
Press Releases
Kivu Bioscience Presents KIVU-305 Preclinical Data at World ADC London 2026 and Advances into Phase 1 Clinical Trial
February 26, 2026
 · 
3 min read
Press Releases
Mahzi Therapeutics Announces First Patient Dosed in Phase 1/2 UNITE Study of MZ-1866 for Pitt Hopkins Syndrome
February 26, 2026
 · 
4 min read
Press Releases
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
February 25, 2026
 · 
11 min read
Press Releases
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE034, a Potential First-In-Class B7H3/PTK7 Bispecific TOP1 ADC
February 25, 2026
 · 
5 min read
Press Releases
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
February 25, 2026
 · 
8 min read
Press Releases
FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
February 25, 2026
 · 
7 min read
Press Releases
Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson’s Disease
February 25, 2026
 · 
6 min read
Press Releases
Vico Therapeutics Announces Patient Dosing in Twice-Annual Regimen of VO659 in Phase 1/2 Trial in Huntington’s Disease, Spinocerebellar Ataxia Type 3 and Type 1
February 24, 2026
 · 
3 min read
Press Releases
Cartography Biosciences Doses First Patient in Phase 1 Trial of CBI-1214, a Highly Specific T-Cell Engager for the Treatment of Colorectal Cancer
February 24, 2026
 · 
4 min read
Press Releases
AtomVie Global Radiopharma Supplies First Patient Dose in Radiopharm Theranostics’ Phase 1/2a Clinical Study of 177Lu-BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)
February 24, 2026
 · 
4 min read
Press Releases
Monte Rosa Therapeutics Presents Updated Clinical Data from Phase 1/2 Study of MRT-2359 in Combination with Enzalutamide in Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer Patients at ASCO Genitourinary Cancers Symposium (ASCO GU)
February 24, 2026
 · 
10 min read
Press Releases
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
February 24, 2026
 · 
6 min read
Press Releases
Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
February 24, 2026
 · 
11 min read
Press Releases
Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Patients with Asthma with its Novel Bispecific Anti-TSLP/IL-4Rα Antibody ATI-052
February 24, 2026
 · 
5 min read
Press Releases
Centauri Therapeutics Extends Series A to £30M With £6M Investment From AMR Action Fund to Support Progression of Lead Clinical Candidate
February 24, 2026
 · 
3 min read
Press Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
 · 
20 min read
Press Releases
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
February 24, 2026
 · 
10 min read
Press Releases
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 24, 2026
 · 
9 min read
Load More